Y-Intercept (HK)
SLN icon

Y-Intercept (HK)’s Silence Therapeutics SLN Stock Holding History

Y-Intercept (HK)’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$438K Buy
+40,107
New +$488K 0.01% 1326
2025
Q1 		– Sell
-21,217
Closed -$146K – 1572
2024
Q4 		$146K Buy
21,217
+139
+0.7% +$1.79K 0.01% 1079
2024
Q3 		$383K Buy
21,078
+3,923
+23% +$73K 0.02% 908
2024
Q2 		$326K Buy
+17,155
New +$365K 0.02% 1005

Other funds holding SLN

Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Y-Intercept (HK)'s SLN Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Silence Therapeutics (SLN) in Q3 2026: 40,107 shares worth $438K. The stake represents 0.01% of the portfolio and ranks #1326 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in SLN as recently as Q4 2024.

Y-Intercept (HK) first reported a position in SLN in Q2 2024 and has held it in 4 quarters since. 16 funds tracked by Wall St. Rank hold SLN as of Q3 2026.

  • Y-Intercept (HK) held 40,107 shares of Silence Therapeutics worth $438K as of Q3 2026.
  • Silence Therapeutics was a new Y-Intercept (HK) position in Q3 2026.
  • Silence Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1326 holding.
  • Y-Intercept (HK) first reported a position in Silence Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 16 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.